Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells

BMB Reports

Volumn 46, Issue 4, 2013, Pages 207-212

  Quan, Hai Yan ^a   Kim, Do Yeon ^a   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

AMP activated protein kinase; Caffeine; HepG2 cells; Lipid accumulation; Sterol regulatory element binding protein

Indexed keywords

(6 (4 (2 PIPERIDIN 1 YLETHOXY)PHENYL)) 3 PYRIDIN 4 YLPYRAZOLO(1,5 A)PYRIMIDINE; (6-(4-(2-PIPERIDIN-1-YLETHOXY)PHENYL))-3-PYRIDIN-4-YLPYRAZOLO(1,5-A)PYRIMIDINE; ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; CAFFEINE; CD36 ANTIGEN; CHOLESTEROL; FAS ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL;

ARTICLE; CELL STRAIN HEPG2; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; LIPOGENESIS; LIPOLYSIS; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANTIGENS, CD36; ANTIGENS, CD95; CAFFEINE; CHOLESTEROL; HEP G2 CELLS; HUMANS; LIPOGENESIS; LIPOLYSIS; PHOSPHORYLATION; PYRAZOLES; PYRIMIDINES; RECEPTORS, LDL; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEAROYL-COA DESATURASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

EID: 84880602843     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2013.46.4.153     Document Type: Article

References (23)

1. Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Buqianesi, E., Lenzi, M., McCullough, A., Natale, S., Forlani, G. and Melchionda, N. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50, 1884-1850.
2. Hardie, D. G. (2008) AMPK: a key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. 32, S7-S12.
3. Hardie, D. G., Corton, J., Ching, Y. P., Davies, S. P. and Hawley, S. (1997) Regulation of lipid metabolism by the AMP-activated protein kinase. Biochem. Soc. Trans. 25, 1229-1231.
4. Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y. L. and Schulze, A. (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224-236.
5. You, M., Matsumoto, M., Pacold, C. M., Cho, W. K. and Crabb, D. W. (2004) The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127, 1798-1808.
6. Lee, W. J. (2006) AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARa and PGC-1. Biochem. Biophys. Res. Commun. 340, 281-295.
7. Keijzers, G. B., De Galan, B. E., Tack, C. J. and Smits P. (2002) Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25, 364-369.
8. Duffey, K. J. and Popkin, B. M. (2007) Shifts in patterns and consumption of beverages between 1965 and 2002. Obesity 15, 2739-2747.
9. Paynter, N. P., Yeh, H. C., Voutilainen, S., Schmidt, M. I., Heiss, G., Folsom, A. R., Brancati, F. L. and Kao, W. H. (2006) Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Am. J. Epidemiol. 164, 1075-1084.
10. Tuomilehto, J., Hu, G., Bidel, S., Lindstrom, J. and Jousilahti, P. (2004) Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291, 1213-1219.
11. McCarty, M. F. (2005) A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk. Med. Hypotheses 64, 848-853.
12. Nakabayashi, H., Hashimoto, T., Ashida, H., Nishiumi, S. and Kanazawa, K. (2008) Inhibitory effects of caffeine and its metabolites on intracellular lipid accumulation in murine 3T3-L1 adipocytes. Biofactors 34, 293-302.
13. Murosaki, S., Lee, T. R., Muroyama, K., Shin, E. S., Cho, S. Y., Yamamoto, Y. and Lee, S. J. (2007) A combination of caffeine, arginine, soy isoflavones, and L-carnitine enhances both lipolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo. J. Nutr. 137, 2252-2257.
14. Eberlé, D., Hegarty, B., Bossard, P., Ferré, P. and Foufelle, F. (2004) SREBP transcription factors: master regulators of lipid homeostasis. Biochimi. 86, 839-848.
15. Kim, S. J., Jung, J. Y., Kim, H. W. and Park, T. (2008) Anti-obesity effects of Juniperus chinensis extract are associated with increased AMP-activated protein kinase expression and phosphorylation in the visceral adipose tissue of rats. Biol. Pharm. Bull. 31, 415-421.
16. Ching, Y. P., Davies, S. P. and Hardie, D. G. (1996) Analysis of the specificity of the AMP-activated protein kinase by site-directed mutagenesis of bacterially expressed 3-hydroxy 3-methylglutaryl-CoA reductase, using a single primer variant of the unique-site-elimination method. Eur. J. Biochem. 237, 800-808.
17. Pallottini, V., Montanari, L., Cavallini, G., Bergamini, E., Gori, Z. and Trentalance, A. (2004) Mechanisms underlying the impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in aged rat liver. Mech. Ageing Dev. 125, 633-639.
18. Department of Agriculture Agricultural Research Service: USDA. National Nutrient Database for Standard Reference (2007).
19. Nagle, C. A., Klett, E. L. and Coleman, R. A. (2009) Hepatic triacylglycerol accumulation and insulin resistance. J. Lipid Res. 50, S74-79.
20. Summers, S. A. (2006) Ceramide in insulin resistance and lipotoxicity. Prog. Lipid Res. 45, 42-72.
21. Horton, J. D., Goldstein, J. L. and Brown, M. S. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131.
22. Saha, A. K. and Ruderman, N. B. (2003) Malonyl-CoA and AMP-activated protein kinase: an expanding partnership. Mol. Cell Biochem. 253, 65-70.
23. Hardie, D. G. and Pan, D. A. (2002) Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem. Soc. Trans. 30, 1064-1070.